AM Press ReleasesMedical AMProsthetics

BellaSeno reports positive one-year patient follow-up data

For the company's 3D printed resorbable breast and pectus excavatum scaffolds

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, has reported encouraging one-year follow-up data of its 3D printed breast and pectus excavatum scaffolds.

Both pectus and breast implants demonstrated a very good safety profile, were very well accepted by the surgeons, and patients expressed high satisfaction and reported an improvement in quality of life. A significant improvement in pain scores was observed in breast reconstruction patients with prior silicone implants. All patients’ breasts maintained their shape and volume after surgery.

The majority of patients enrolled in the trial have been treated already (13 of 20 breast, and 9 of 10 pectus reconstruction patients, respectively) and it is expected that all patients will undergo surgery by the end of this year. BellaSeno is therefore planning an expansion of the trial into a multi-center study with several trial sites in Europe and Australia.

BellaSeno reports positive one-year patient follow-up data for the company's 3D printed resorbable breast and pectus excavatum scaffolds.
BellaSeno’s 3D printed breast implants.

With its resorbable breast and pectus excavatum scaffolds, BellaSeno has developed leading-edge 3D printed products for plastic and reconstructive surgeries. The company has already demonstrated superior properties of its medical scaffolds and reported the data at scientific meetings and in peer-reviewed publications.

“The positive one-year follow-up is a key milestone for our breast and pectus excavatum scaffolds,” said Mohit Chhaya, CEO of BellaSeno. “The data brings us closer to realizing our vision of providing breakthrough innovations in the world of breast surgery by offering personalized care options. First-in-human data have been very promising so far, demonstrating excellent safety of the scaffolds and high acceptance of the products among surgeons and patients. Moreover, patient recruitment is going well, which confirms that there is a significant need for alternatives to silicone implants.”

BellaSeno’s ISO 13485-certified manufacturing platform is designed to meet the requirements of medical scaffolds ranging from soft tissue to bone and enables the production of both custom-made and off-the-shelf sterile medical implants.

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...


VoxelMatters is the online trade media portal published by 3dpbm, a leading marketing and market research firm specializing in the AM industry. 3dpbm also publishes the 3D Printing Business Directory, the AM Focus eBook series and the 3dpbm Research AM Market Reports. 3D Printing Media Network was founded with the goal to provide the latest industry news, insights and opinions to a global audience of professionals and decision makers.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.